4D Molecular Therapeutics Inc Free Cash Flow Generation Index

Latest as of December 2025: 0.98x

4D Molecular Therapeutics Inc free cash flow generation index. 4D Molecular Therapeutics Inc (FDMT) has a Free Cash Flow Generation Index of 0.98x as of December 2025. Free cash flow of $27.92 Million represents 1% of operating cash flow ($28.55 Million).

FCF Generation Index

0.98x
Free Cash Flow / Operating CF

Free Cash Flow

$27.92 Million
USD

Operating Cash Flow

$28.55 Million
USD

Capital Expenditures

$631.00K
USD

Free Cash Flow Generation Index of 4D Molecular Therapeutics Inc (2017–2017)

Free cash flow generation index of 4D Molecular Therapeutics Inc from 2017 to 2017. Historical FCF Generation Index trend for 4D Molecular Therapeutics Inc across 1 annual periods. See FDMT financial flexibility index to measure the company's free cash flow as a share of total liabilities.

4D Molecular Therapeutics Inc Free Cash Flow Generation Index by Year (2017–2017)

4D Molecular Therapeutics Inc free cash flow generation index by year from 2017 to 2017. Year-by-year Free Cash Flow Generation Index for 4D Molecular Therapeutics Inc. For the full cash flow conversion analysis, see 4D Molecular Therapeutics Inc (FDMT) cash conversion ratio.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2017 0.93x $7.66 Million $8.24 Million $573.00K —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).